Previous close | 5.90 |
Open | 5.90 |
Bid | 2.40 |
Ask | 4.60 |
Strike | 47.50 |
Expiry date | 2024-07-19 |
Day's range | 5.90 - 5.90 |
Contract range | N/A |
Volume | |
Open interest | 14 |
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
We can readily understand why investors are attracted to unprofitable companies. Indeed, Twist Bioscience ( NASDAQ:TWST...
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.